Background: Michelia nilagirica belonging to the family Mangoliaceae is commonly used by many traditional healers in most of the herbal preparations for diabetes and kidney diseases. Objective: Different fractions isolated from ethanolic extract of whole plant of Michelia nilagirica is investigated for hepatoprotective activity in wistar albino rats against paracetamol induced hepatic injury. Materials & Methods: Rats were divided into eight groups. Each group contains six animals. Hepatic injury was achieved by injecting paracetamol at a dose of 2 mg/kg p.o. Results: The hepatoprotective action is seen with fraction A by reduction in serum marker enzymes like Aspartate transaminase (AST), Alanine transaminase (ALT). It also reduced the elevated levels of Alkaline phosphotase (ALP) & Serum bilirubin. Conclusion: Histopathological studies further confined the hepatoprotective activity of fraction A against paracetamol treated group. The results obtained were compared with silymarin (100 mg/kg, orally), a standard drug.
INTRODUCTION
The liver is a important organ of vertebrates and some other animals and some other animals. It has a wide range of functions like ability to detoxicate toxic substances, 1 synthesis of proteins, production of biochemicals necessary for digestion. Hepatocytes (Liver cells) regulates a variety of biochemical reactions like synthesis and break down of small and complex molecules and many other vital functions. Liver diseases are mainly due to infections, life style (smoking, alcoholism), toxic substances (chemicals & drugs). Hepatotoxic agents damage liver cells by lipid peroxidation and other oxidative damages. In addition, many biochemical markers in the serum like aspartate transaminase 2 (AST), alanine transaminase (ALT), alkaline phosphatase 3 (ALP) and bilirubin 4 were also increased. In absence of a reliable liver protective drug in the modern system of medicine, a number of novel medicinal preparations in Ayurveda, Homeopathy, Unani, the Indian system of medicine are recommended for the treatment of liver disorders. So medicinal plants are considered to be effective and safe natural remedy treatments for hepatotoxicity. 5 Michelia nilagirica, belonging to the genus magnolia (magnoliaceae) is a native to tropical and subtropical South and Southeast Asia, including southern china. It is widely used in both Ayurveda and Homeopathic medicine. Flower buds of Michelia champaca Linn. is commonly used by many traditional healers in most of the herbal preparations for diabetes 6 and kidney diseases. 7 Traditionally, it is being used in fever, colic, leprosy, post partum protection 8 and in eye disorders. 9 It has been reported to possess antipyretic, antiulcer, anti-inflammatory, 10 insecticidal, 11 antioxidant, antimicrobial 8 and leishmanicidal 12 activities. The active constituents reported in this plant are alkaloids, tannins, saponins, sterols, flavonoids and triterpenoids. 8 In Ayurveda, traditional usages of plants are most commonly in their aqueous extracts form only. Concurrently, some of the papers searched focus for testing these plants in their ethanolic or aqueous extracts and some have also reported activity in petroleum ether, benzene and chloroform extracts. [13] [14] [15] Keeping these facts in view, the present study was undertaken to create a scientific base for the use of the extract of Michelia nilagirica as a hepatoprotective agent.
Paracetamol is a commonly used analgesic & antipyretic agent. The main adverse effects of paracetamol overdose are hepatotoxicity & nephrotoxicity which could be fatal. Its metabolite N-acetyl-p-benzoquinoneimine (NAPQI) which is normally detoxified by glutathione is responsible for hepatotoxicity. Excess of NAPQI is formed in paracetamol overdose which binds to proteins and other macromolecules resulting in hepatic necrosis. The standard therapy for paracetamol overdose is N-acetylcysteine. It restores hepatic glutathione which detoxifies NAQPI. 16 Some cases do not respond, 17 though N-acetylcysteine is used for the treatment of paracetamol toxicity. In spite of tremendous advances in modem medicine, there are hardly any reliable drugs that protect the liver from damage and/or help in regeneration of hepatocytes. To treat a wide variety of clinical diseases including liver disease many active plant extracts are frequently utilized. Therefore, searching for effective and safe drugs for liver disorders are continues to be an area of interest.
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MATERIALS AND METHODS
Collection of plant material
The whole plant of Michelia nilagirica was collected from the deciduous forest of Tirumala Hills in Andhra Pradesh State, India. Samples were authenticated by Dr. K. Madhava Chetty, Department of Botany, Sri Venkateswara University, Tirupati, India. The whole plant of Michelia nilagirica were sorted, cleaned and air-dried at room temperature for one week. By using the laboratory hammer mill these were ground to powder. Powdered samples were collected and stored in air-and water-proof containers protected from direct sunlight and heat until required for extraction.
Preparation of extracts
The powdered materials of Michelia nilagirica (whole plant) were extracted successively each for 18 hrs with petroleum ether, ethyl acetate, chloroform, ethanol and distilled water in soxhlet apparatus. The extracts were concentrated to dryness in rota evaporator till free from the solvents.
Isolation of fractions
Thin-layer chromatography method was carried out using silica gel aluminum plate 60F-254, 0.5 mm (TLC plates, Merck). The spots were visualized in UV light and 10% of H 2 SO 4 in methanol. The ethanolic extract was subjected to column chromatography (silica gel 60-100) for further purification. The equilibration of column was carried for one hour with petroleum ether at flow rate 5ml/min. The sample was (2 gm dissolve in acetone) loaded on to the column, 8 fractions were collected using petroleum ether:ethyl acetate (4:1), petroleum ether:ethyl acetate (1:1), petroleum ether:ethyl acetate (2:3), ethyl acetate (100%), chloroform:methanol (9:1), chloroform:methanol (1:1) and chloroform:methanol (2:8).
Above yielded product were pooled into five fractions based on TLC. The yield and appearance of the five 
Phytochemical analysis
Phytochemical analysis 19 of fractions was carried out for the presence of alkaloids, tannins, saponins, glycosides, terpenoids, carbohydrates, flavonoids, proteins, amino acids, fixed oils, steroids & sterols by different methods.
Experimental design
Albino rats of wistar strain weighing 150-200 gm were purchased from National Institute of Nutrition, Hyderabad. The rats were kept in polypropylene cages (3 in each cage) at an ambient temperature of 25 ± 2°C and relative humidity of 55-65%. A 12 hrs light and dark schedule was maintained in the air conditioned animal house. All the rats were fed with common diets for week after arrival and then divided into groups with free access to food and water.
Acute toxicity studies
Toxicological studies were conducted in 3 groups of 5 mice and the extract is administered at the doses of 150, 300 and 1000 mg/kg no mortality was observed. They were observed continuously for 1 hr for any gross behavioral changes, symptoms of toxicity and mortality if any after dosing with Michelia nilagirica ethanol extract.
Study design
Rats were divided into 6 groups of six animals in each. 
Histopathological studies
The liver tissue was collected, fixed in 10% formalin and stained with hematoxylin and eosin for photomicroscopic observation.
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Statistical analysis
The data was represented as Mean±SD. Results were analysed by One-Way ANOVA followed by Dunnett's multiple comparison test using SPSS software. The minimum level of significance was set at p<0.05. (Figures 1-5 ).
RESULTS
Preliminary phytochemical screening
Histopathological examination
Photographs showing histopathology of liver sections (5-10 μ), 40X, Haematoxylin-eosin stain. A) Control group (tween 80) showed normal histology, B) Paracetamol (2 gm/kg) treated group showed cellular degeneration, hydropic changes, fatty changes with wide spread hepatocellular necrosis, C) Silymarin (100 mg/kg) + paracetamol (2 mg/kg) treated group showed very little necrosis or degeneration, D) Fraction A (7 0 mg/kg) + paracetamol (2 mg/kg) treated group showed no hepatocellular damage except areas of focal degeneration and sinusoidal dilation, E) Fraction B (70 mg/kg) + paracetamol (2 mg/kg) treated group showed minimal hepatocellular damage, fatty changes and loss of liver architecture, F) Fraction C extract (70 mg/kg) + paracetamol (2 mg/kg) treated group showed hepatic necrosis, cellular degeneration, hydropic changes and fatty changes, G) Fraction D extract (70 mg/kg) + paracetamol (2 mg/kg) treated group showed hepatocellular damage and fatty changes, H) Fraction E extract (70 mg/kg) + paracetamol (2 mg/kg) treated group showed hepatic necrosis, cellular degeneration, hydropic changes and fatty changes ( Figure 6 ).
DISCUSSION
Paracetamol is a common analgesic and antipyretic drug. Several studies have demonstrated the induction of hepatocellular damage or necrosis by paracetamol higher doses in experimental animals and humans. 25 For screening of hepatoprotective agents, paracetamol-induced hepatotoxicity has been used as a reliable method. Paracetamol is metabolized primarily in the liver and eliminated by conjugation with sulfate and glucuronide, and then excreted by the kidney. Moreover, paracetamol hepatotoxicity has been attributed to the formation of toxic metabolites, when a part of paracetamol is activated by hepatic cytochrome P-450 to a highly reactive metabolite Nacetyl-p-benzoquinoneimine 26 (NAPQI). Toxic metabolites (N-acetyl-p-benzoquineimine) can alkylate and oxidise intracellular GSH, which results in liver GSH depletion subsequently leads to increased lipid peroxidation by abstracting hydrogen from a polyunsaturated fatty acid and ultimately, liver damage due to higher doses of paracetamol. 27, 28 Reactive metabolites can exert initial cell stress through a wide range of mechanisms including depletion of glutathione (GSH) or binding to enzymes, lipids, nucleic acids and other cell structures. 29 Acute paracetamol administration significantly increased the level of liver injury marker enzymes like AST, ALP, ALP and bilirubin (The liver marker enzymes were 240 ± 2.8 U/L, 185.5 ± 9.8 U/L, 647.8 ± 39.5 U/L and 2.18 ± 0.31 mg/dl for the AST, ALP, ALP and bilirubin respectively). A similar experimental procedure also used by other researchers to report the hepatoprotective effect of natural products. 30 The present study reported the degree of protection, measured by using biochemical parameters like AST, ALT, ALP and bilirubin in fractions treated rats.
Studies showed that the pretreatment with Michelia nilagirica fraction A (70 mg/kg) for seven days offers considerable protection (P<0.05) to liver as evidenced from the levels of biochemical parameters (The liver marker enzymes were 155.5 ± 15.5, 121 ± 3.53, 427.5 ± 14.8 & 1.15 ± 0.23 for A) Control group (tween 80) showed normal histology, B) Paracetamol (2 gm/kg) treated group showed cellular degeneration, hydropic changes, fatty changes with wide spread hepatocellular necrosis, C) Silymarin (100 mg/kg) + paracetamol (2 mg/kg) treated group showed very little necrosis or degeneration, D) Fraction A (70 mg/kg) + paracetamol (2 mg/kg) treated group showed no hepatocellular damage except areas of focal degeneration and sinusoidal dilation, E) Fraction B (70 mg/kg) + paracetamol (2 mg/kg) treated group showed minimal hepatocellular damage, fatty changes and loss of liver architecture, F) Fraction C extract (70 mg/kg) + paracetamol (2 mg/kg) treated group showed hepatic necrosis, cellular degeneration, hydropic changes and fatty changes, G) Fraction D extract (70 mg/kg) + paracetamol (2 mg/kg) treated group showed hepatocellular damage and fatty changes, H) Fraction E extract (70 mg/kg) + paracetamol (2 mg/kg) treated group showed hepatic necrosis, cellular degeneration, hydropic changes and fatty changes.
the AST, ALT, ALP and bilirubin respectively) and similarly fraction B (70 mg/kg) significantly (P<0.05) reduced raising serum enzymes in hepatotoxic rats (Table 1) . Pretreatment with fraction D and E (70 mg/kg) resulted no significant reduction in serum AST, ALT, ALP and bilirubin compared to fraction A and B treated groups (Table 2) .
CONCLUSION
Flavonoids
31 are a class of secondary plant phenolics found in fruits, vegetables and foods, which act as pharmacological active compound in many medicinal plants. Many of the biological action of flavonoids 32 have been attributed their powerful antioxidant properties 33 and number of scientific reports indicated that certain flavonoids, terpenoids have protective effect on liver due to its antioxidant properties. 34 Present study fraction A contain valuable flavonoids, that shown hepatoprotective activity through regulatory action on cellular permeability, stability and suppressing oxidative stress by their antioxidant property.
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